| Citation: |
LIU Sujuan, WANG Yong, LI Ran, LI Haidong, LIU Jie. Correlation Between Hyperbaric Oxygen Therapy Course and Reduction of Clonazepam in Patients with Paroxysmal Sympathetic Hyperactivity: A Retrospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 386-392. DOI: 10.12290/xhyxzz.2024-0378
|
To analyze the correlation between the duration of hyperbaric oxygen (HBO) therapy and oral medication clonazepam reduction in patients with paroxysmal sympathetic hyperactivity (PSH).
Clinical data of patients with secondary PSH after severe brain injury at Capital Medical University Affiliated Fuxing Hospital from September 2017 to July 2023 were retrospectively included, covering general information, etiology, lesion location, comorbidities, vital signs at admission, PSH attack characteristics, HBO treatment frequency, PSH treatment drugs and dosage. According to the number of HBO treatments, PSHpatients were divided into HBO short course group (10 treatments) and HBO long course group (>10 treatments). Multiple logistic regression and rank correlation analysis were used to investigate the correlation between the duration/frequency of HBO treatment and the reduction of clonazepam.
A total of 75 PSH patients who met the inclusion and exclusion criteria were selected, including 38 cases (50.7%) who received reduced doses of clonazepam. There were 32 cases (42.7%) in the HBO short course group and 43 cases (52.3%) in the HBO long course group. The reduction rate of clonazepam in the HBO short course group was lower than that in the HBO long course group[31.3% (10/32) vs.65.1% (28/43), crude OR=4.11 (95% CI: 1.55-10.90), P=0.004]. After adjusting for confounding variables, a multivariate Logistic regression model showed a significant correlation between HBO long course and clonazepam reduction (OR= 3.76, 95% CI: 1.23-11.55, P=0.021). Rank correlation analysis showed a positive correlation between HBO treatment frequency and clonazepam reduction (rs=0.331, P=0.004).
Long course HBO treatment was positively correlated with oral reduction of clonazepam in PSH patients, which may help reduce the side effects caused by clonazepam and become a non- pharmacological treatment option for PSH.
| [1] |
Podell J, Pergakis M, Yang S M, et al. Leveraging continuous vital sign measurements for real-time assessment of autonomic nervous system dysfunction after brain injury: a narrative review of current and future applications[J]. Neurocrit Care, 2022, 37(S2): 206-219. DOI: 10.1007/s12028-022-01491-6
|
| [2] |
Khalid F, Yang G L, McGuire J L, et al. Autonomic dysfu nction following traumatic brain injury: translational insights[J]. Neurosurg Focus, 2019, 47(5): E8. DOI: 10.3171/2019.8.FOCUS19517
|
| [3] |
Grimberg-Peters D, Büren C, Windolf J, et al. Hyperbaric oxygen reduces production of reactive oxygen species in neutrophils from polytraumatized patients yielding in the inhibition of p38 MAP kinase and downstream pathways [J]. PLoS One, 2016, 11(8): e0161343. DOI: 10.1371/journal.pone.0161343
|
| [4] |
Whyte J, Nordenbo A M, Kalmar K, et al. Medical complications during inpatient rehabilitation among patients with traumatic disorders of consciousness[J]. Arch Phys Med Rehabil, 2013, 94(10): 1877-1883. DOI: 10.1016/j.apmr.2012.12.027
|
| [5] |
Choi H A, Jeon S B, Samuel S, et al. Paroxysmal sympathetic hyperactivity after acute brain injury[J]. Curr Neurol Neurosci Rep, 2013, 13(8): 370. DOI: 10.1007/s11910-013-0370-3
|
| [6] |
邵峰, 金丽, 沈寿引, 等. 重症自发性脑出血阵发性交感神经兴奋综合征的发生因素及对患者预后的影响[J]. 临床急诊杂志, 2022, 23(3): 187-191.
Shao F, Jin L, Shen S Y, et al. Study on the factors of paroxysmal sympathetic hyperactivity and its influence on the prognosis in patients with cerebral hemorrhage[J]. J Clin Emerg, 2022, 23(3): 187-191.
|
| [7] |
Lv L Q, Hou L J, Yu M K, et al. Hyperbaric oxygen therapy in the management of paroxysmal sympathetic hyperactivity after severe traumatic brain injury: a report of 6 cases [J]. Arch Phys Med Rehabil, 2011, 92(9): 1515-1518. DOI: 10.1016/j.apmr.2011.01.014
|
| [8] |
Choi S, Kim H H, Oh S B, et al. Repetitive hyperbaric oxygen therapy for paroxysmal sympathetic hyperactivity after acute carbon monoxide poisoning[J]. Undersea Hyperb Med, 2021, 48(4): 431-441. http://pubmed.ncbi.nlm.nih.gov/34847307/
|
| [9] |
刘金强, 高建凯, 刘亚杰, 等. 高压氧治疗心肺复苏后阵发性交感神经过度兴奋综合征[J]. 中华实用诊断与治疗杂志, 2023, 37(12): 1255-1259.
Liu J Q, Gao J K, Liu Y J, et al. Hyperbaric oxygen therapy for paroxysmal sympathetic hyperactivity syndrome after cardiopulmonary resuscitation[J]. J Chin Pract Diagn Ther, 2023, 37(12): 1255-1259.
|
| [10] |
Wang H Y, Li Y H, Zhao M, et al. The effects of hyperbaric oxygen therapy on paroxysmal sympathetic hyperactivity after cardiopulmonary resuscitation: a case series[J]. World J Emerg Med, 2023, 14(6): 477-480. DOI: 10.5847/wjem.j.1920-8642.2023.092
|
| [11] |
Baguley I J, Perkes I E, Fernandez-Ortega J F, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria[J]. J Neurotrauma, 2014, 31(17): 1515-1520.
|
| [12] |
Yin J T, Wang W, Wang Y, et al. Risk factors and clinical outcomes of basilar artery occlusion presenting with paroxysmal sympathetic hyperactivity as the initial manifestation: a prospective study[J]. J Neurointerv Surg, 2024, 16(9): 892-896. DOI: 10.1136/jnis-2023-020692
|
| [13] |
Scott R A, Rabinstein A A. Paroxysmal sympathetic hyperactivity[J]. Semin Neurol, 2020, 40(5): 485-491. DOI: 10.1055/s-0040-1713845
|
| [14] |
Lucca L F, Pignolo L, Leto E, et al. Paroxysmal sympathetic hyperactivity rate in vegetative or minimally conscious state after acquired brain injury evaluated by paroxysmal sympathetic hyperactivity assessment measure[J]. J Neurotrauma, 2019, 36(16): 2430-2434. DOI: 10.1089/neu.2018.5963
|
| [15] |
Tu J S Y, Reeve J, Deane A M, et al. Pharmacological management of paroxysmal sympathetic hyperactivity: a scoping review[J]. J Neurotrauma, 2021, 38(16): 2221-2237. DOI: 10.1089/neu.2020.7597
|
| [16] |
Podell J E, Miller S S, Jaffa M N, et al. Admission features associated with paroxysmal sympathetic hyperactivity after traumatic brain injury: a case-control study[J]. Crit Care Med, 2021, 49(10): e989-e1000. http://pubmed.ncbi.nlm.nih.gov/34259439/
|
| [17] |
Zheng R Z, Lei Z Q, Yang R Z, et al. Identification and management of paroxysmal sympathetic hyperactivity after traumatic brain injury[J]. Front Neurol, 2020, 11: 81. DOI: 10.3389/fneur.2020.00081
|
| [18] |
Pozzi M, Conti V, Locatelli F, et al. Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: clinical factors and acute pharmacological management[J]. J Head Trauma Rehabil, 2015, 30(5): 357-363. DOI: 10.1097/HTR.0000000000000084
|
| [19] |
Van Eijck M M, Sprengers M O P, Oldenbeuving A W, et al. The use of the PSH-AM in patients with diffuse axonal injury and autonomic dysregulation: a cohort study and review[J]. J Crit Care, 2019, 49: 110-117. DOI: 10.1016/j.jcrc.2018.10.018
|
| [20] |
Thomas A, Greenwald B D. Paroxysmal sympathetic hyperactivity and clinical considerations for patients with acquired brain injuries: a narrative review[J]. Am J Phys Med Rehabil, 2019, 98(1): 65-72. DOI: 10.1097/PHM.0000000000000990
|
| [21] |
Totikov A, Boltzmann M, Schmidt S B, et al. Influence of paroxysmal sympathetic hyperactivity (PSH) on the fu nctional outcome of neurological early rehabilitation patients: a case control study[J]. BMC Neurol, 2019, 19(1): 162. DOI: 10.1186/s12883-019-1399-y
|
| [22] |
Hughes J D, Rabinstein A A. Early diagnosis of paroxysmal sympathetic hyperactivity in the ICU[J]. Neurocrit Care, 2014, 20(3): 454-459. DOI: 10.1007/s12028-013-9877-3
|
| [23] |
Xu S Y, Zhang Q, Li C X. Paroxysmal sympathetic hyperactivity after acquired brain injury: an integrative review of diagnostic and management challenges[J]. Neurol Ther, 2024, 13(1): 11-20. DOI: 10.1007/s40120-023-00561-x
|
| [24] |
Raithel D S, Ohler K H, Porto I, et al. Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hyperactivity after hypoxic brain injury[J]. J Pediatr Pharmacol Ther, 2015, 20(4): 335-340. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557724/pdf/i1551-6776-20-4-335.pdf
|
| [25] |
Pena A B, Caviness J N. Physiology-based treatment of myoclonus[J]. Neurotherapeutics, 2020, 17(4): 1665-1680. DOI: 10.1007/s13311-020-00922-6
|
| [26] |
Xu Y, Wan L, Ning J, et al. Paroxysmal sympathetic hyperactivity in a child with tuberculous meningitis a case study and review of related literature[J]. West Indian Med J, 2015, 64(5): 543-547. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961345/pdf/wimj-64-0543.pdf
|
| [27] |
Zhu K X, Zhu Y B, Hou X X, et al. NETs Lead to sympathetic hyperactivity after traumatic brain injury through the LL37-Hippo/MST1 pathway[J]. Front Neurosci, 2021, 15: 621477. http://pubmed.ncbi.nlm.nih.gov/33994918/
|
| [28] |
Fernandez-Ortega J F, Baguley I J, Gates T A, et al. Catecholamines and paroxysmal sympathetic hyperactivity after traumatic brain injury[J]. J Neurotrauma, 2017, 34(1): 109-114. DOI: 10.1089/neu.2015.4364
|
| [29] |
Davidson J R T, Foa E B, Connor K M, et al. Hyperhidrosis in social anxiety disorder[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2002, 26(7/8): 1327-1331. http://www.sweathealth.info/pdf/Davidson_2002.pdf
|
| [1] | ZHOU Yongtai, YANG Zhenyu, LI Yan, WU Jiajing, ZHAO Bo. Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 330-337. DOI: 10.12290/xhyxzz.2025-0028 |
| [2] | LAI Xinxiu, WANG Xiang. Application Status and Research Advances of Artificial Intelligence in Pancreatobiliary Endoscopy[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 387-393. DOI: 10.12290/xhyxzz.2023-0524 |
| [3] | MA Mingsheng, SONG Hongmei. Acceleration of Precision Medicine in Pediatric Rheumatic and Immunologic Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 229-233. DOI: 10.12290/xhyxzz.2023-0080 |
| [4] | WANG Guochang, ZHU Zhaohui. Molecular Imaging-guided Precise Theranostics[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 165-168. DOI: 10.12290/xhyxzz.2021-0773 |
| [5] | CHEN Wen, ZHOU Zhou. Application of Genetic Testing in Precision Medicine for Coronary Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 445-449. DOI: 10.12290/xhyxzz.2021-0418 |
| [6] | LIU Yan-hong, YE Qing. The Characteristics of the Construction and Development of Biobank in the Era of Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 254-259. DOI: 10.3969/j.issn.1674-9081.2020.00.008 |
| [7] | Yue-kun WANG, Peng-hao LIU, Yu WANG, Wen-bin MA. Single-cell Sequencing and Its Prospect in the Management of Brain Malignant Tumor[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 606-614. DOI: 10.3969/j.issn.1674-9081.2020.05.018 |
| [8] | Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. DOI: 10.3969/j.issn.1674-9081.2019.01.002 |
| [9] | Bo ZHANG. Development of Pathology in Coming Era of Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 117-121. DOI: 10.3969/j.issn.1674-9081.2017.03.007 |
| [10] | Cardiovascular Intervention: A Companion to Braunwald's Heart Disease(2016)[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(1): 65-65. |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: